nifedipine has been researched along with Anemia, Hemolytic in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osafune, K | 1 |
| Iehara, N | 1 |
| Takeoka, H | 1 |
| Doi, T | 1 |
| Kita, T | 1 |
1 other study available for nifedipine and Anemia, Hemolytic
| Article | Year |
|---|---|
Nifedipine and haemolytic anaemia.
Topics: Anemia, Hemolytic; Calcium Channel Blockers; Hemoglobins; Humans; Male; Middle Aged; Nifedipine | 2000 |